Abstract
Selenium, an essential biological trace element present in both prokaryotic and eukaryotic cells, exerts its regulatory effect in a variety of cellular events, including cell growth, survival, and death. Selenium compunds have been shown in different cell lines to inhibit apoptosis by several mechanisms. Serine/threonine phosphatases (STPs) are potentially important in selenite-induced apoptosis because of their role in regulation of diverse set of cellular processes. In this study, the regulatory role of STPs in selenite-induced apoptosis has been implied by the use of two specific inhibitors: ocadaic acid and calyculin A. Our results show a decrease in cell density in HepG2 cells under selenite treatment. Resulting specific enzyme activities showed a concentration-dependent increase in all three phosphatase activities after 24 h in cells treated with 5 μM selenite and these activities decreased at 48 and 72 h. However, in cells treated with 10μM selenite, PP2A and PP2B decreased at 48 h, whereas PP2C activity did not change at this dose. In cells treated with 25μM, there was not a significant change in PP2C activity. These data suggest that the most specific response to selenite treatment was in PP2A and PP2B activities in a dose-dependent manner. Our results with OA and Cal-A further support the view that PP1 and PP2A might act as negative regulators of growth. With these data, we have first demonstrated the role of serine/threonine protein phosphatases in the signaling pathway of selenite-induced apoptosis and resulting cytotoxicity
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
D. Medina et al., Selenium and mouse mammary tumorigenesis: an investigation of possible mechanisms,Cancer Res. 43(5 Suppl.), 2460–2464 (1983).
D. Medina and C. J. Oborn, Selenium inhibition of DNA synthesis in mouse mammary epithelial cell line YN-4,Cancer Res. 44, 4361–4365 (1984).
R. J. Shamberger, The genotoxicity of selenium,Mutat. Res. 154, 29–48 (1985).
M. Jacobs and C. Frost, Toxicological effects of sodium selenite in Sprague-Dawley rats,J Toxicol. Environ. Health 8, 575–585 (1981).
R. Gopalakrishna et al., Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: its role in inhibition of tumor promotion,Arch. Biochem. Biophys. 348, 37–48 (1997).
M. L. Handel et al., Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos,Proc. Natl. Acad. Sci. USA 92, 4497–4501 (1995).
I. Y. Kim and T. C. Stadtman, Inhibition of NF-kappaB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment,Proc. Natl. Acad. Sci. USA 94, 12,904–12,907 (1997).
H. S. Park, E. Park, M. S. Kim, et al., Selenite inhibits the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) through a thiol redox mechanism,J. Biol. Chem. 275, 2527–2531 (2000).
G. Spyrou et al., AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione,FEBS Lett. 368, 59–63 (1995).
S. R. Stapleton et al., Selenium: potent stimulator of tyrosyl phosphorylation and activator of MAP kinase,Biochim. Biophys. Acta 1355, 259–269 (1997).
T. C. Stadtman, Selenocysteine,Annu. Rev. Biochem. 65, 83–100 (1996).
J. Lu et al., Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells,Biochem. Pharmacol. 47(9), 1531–1535 (1994).
J. Lanfear et al., The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium?Carcinogenesis 15(7), 1387–1392 (1994).
Z. Zhu, M. Kimura, Y. Itokawa, et al., Apoptosis induced by selenium in human glioma cell lines,Biol. Trace Element Res. 54(2), 123–134 (1996).
R. Sinha and D. Medina, Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells,Carcinogenesis 18(8), 1541–1547 (1997).
C. Jiang et al., Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake,Mol. Carcinog. 26(4), 213–225 (1999).
R. Sinha, S. C. Kiley, J. X. Lu, et al., Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells,Cancer Lett. 146(2), 135–145 (1999).
H. S. Park, S. H. Huh, Y. Kim, et al., Selenite negatively regulates caspase-3 through a redox mechanism,J. Biol. Chem. 275(12), 8487–8491 (2000).
M. Chigbrow, M. Nelson, et al., Inhibition of mitotic cyclin B and cdc2 kinase activity by selenomethionine in synchronized colon cancer cells,Anticancer Drugs 12(1), 43–50 (2001).
C. Jiang et al., Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells,Cancer Res. 61(7), 3062–3070 (2001).
C. Jiang et al., Methyl selenium-induced vascular endothelial apoptosis is executed by caspases and principally mediated by p38 MAPK pathway,Nutr. Cancer 49(2), 174–183 (2004).
K. Yamaguchi, G. Uzzo, J. Pimkina, et al., Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis,Oncogene in press (2005).
M. B. Yin, Z. R. Li, S. Cao, et al., Enhanced 7-ethyl-10-hydroxycamptothecin (SN-38) lethality by methylselenocysteine is associated with Chk2 phosphorylation at threonine-68 and down-regulation of Cdc6 expression,Mol. Pharmacol. 66(1), 153–160 (2004).
G. E Combs, Jr., Chemopreventive agents: selenium,Pharmacol. Ther. 79, 179–192 (1998).
H. A. Celik et al., Biochemical and morphological characteristics of selenite-induced apoptosis in human hepatoma Hep G2 cells,Biol. Trace Element Res. 99(1–3), 27–40 (2004).
K. Tachibana, P. J. Scheuer, Y. Tsukitani, et al., Okadaic acid, a cytotoxic polyether from two marine sponges of the genusHalichondria, J. Am. Chem. Soc. 103(9), 2469–2471 (1981).
A. Takai, C. Bialojan, M. Troschka, and J. C. Ruegg, Smooth muscle myosin phosphatase inhibition and force enhancement by black sponge toxin,FEBS Lett. 217(1), 81–84 (1987).
R. T. Boudreau, R. Garduno, and T. J. Lin, Protein phosphatase 2A and protein kinase C alpha are physically associated and are involved inPseudomonas aeruginosa-induced interleukin 6 production by mast cells,J. Biol. Chem. 277(7), 5322–5329 (2002).
Y. Kato, N. Fusetani, S. Matsunaga, and K. Hashimoto, Calyculins, potent antitumour metabolites from the marine spongeDiscodermia calyx: biological activities,Drugs Exp. Clin. Res. 14(12), 723–728 (1988).
H. Ishihara, B. L. Martin, D. L. Brautigan, et al., Calyculin A and okadaic acid: inhibitors of protein phosphatase activity,Biochem. Biophys. Res. Commun. 159(3), 871–877 (1989).
P. Cohen, C. E. Holmes, and Y. Tsukitani, Okadaic acid: a new probe for the study of cellular regulation,Trends Biochem. Sci. 15(3), 98–102 (1990).
J. M. Sargent, The use of the MTT assay to study drug resistance in fresh tumour samples,Recent Results Cancer Res. 161, 13–25 (2003).
B. G. Neil and N. K. Tonks, Protein tyrosine phosphatates in signal transduction,Curr. Opin. Cell Biol. 9, 193–204 (1997).
X. Lu et al., PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints,Genes Dev. 19(10), 1162–1174 (2005).
S. St Clair, L. Giono, S. Varmeh Ziaie, et al., DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter,Mol. Cell 16(5), 725–736 (2004).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Celik, H.A., Kircelli, F., Saydam, G. et al. Potential involvement of serine/threonine protein phosphatases in apoptosis of HepG2 cells during selenite treatment. Biol Trace Elem Res 117, 65–75 (2007). https://doi.org/10.1007/BF02698084
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02698084